Silver Book Fact

Since 1950, reduction in heart disease mortality has added more than 3 1/2 years to the expected lifetimes of both men and women.

Murphy, Kevin M. and Robert H. Topel. The Value of Health and Longevity. National Bureau of Economic Research Working Paper. May-2005; 11405. http://www.nber.org/papers/W11405

Reference

Title
The Value of Health and Longevity
Publication
National Bureau of Economic Research Working Paper
Publication Date
May-2005
Authors
Murphy, Kevin M. and Robert H. Topel
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Cost-savings associated with Warfarin use in AFib patients
    Warfarin use in Medicare patients with nonvalvular atrial fibrillation was independently associated with lower medical costs averaging $9,836 per patient, per year.  
  • The projected economic value of eliminating deaths from heart disease is approximately $48 trillion.  
  • A blood thinning drug was found to reduce the risk of heart attack, stroke, and cardiovascular disease by 20% in patients with acute coronary syndrome when given in addition to…  
  • Death rates from stroke have decreased from 180.7 per 100,000 persons in 1950, to 56.2 per 100,000 persons in 2002.  
  • Antihypertensive Medicines Have Prevented Deaths and Hospitalizations: Study quantified impact of high blood pressure drugs on the U.S. population 1999-2000